CGP60474 - CAS# 164658-13-3 Catalog No.:M6799-10 presenting a potential therapeutic strategy

presenting a potential therapeutic strategy against cellular dysfunction and disease resulted from reduced CMA

FH535 also represses angiogenesis in pancreatic cancer xenografts

Landesman Y

InChi: InChI=1S/C27H44N4O5/c1-4-6-8-12-24(34)30-22(18-20-13-15-21(32)16-14-20)26(35)31-25(19(3)5-2)27(36)29-17-10-7-9-11-23(28)33/h13-16

J Clin Invest

CGP60474 - CAS# 164658-13-3 Catalog No.:M6799-10 presenting a potential therapeutic strategyCGP60474, CAS No. 164658 13 3, is a potent dual cdk1 cdk2 inhibitor (IC50 values are 20 and 50 nM, respectively). Also displays low micromolar activity at PKC. Displays reversible G1 S cell cycle arrest in U2 OS cells. Product information CAS Number: 164658 13 3 Molecular Weight: 355. 82 Formula: C18H18ClN5O Synonym: CGP 60474 CGP 60474 Chemical Name: 3 [[4 [2 [(3 Chlorophenyl)amino] 4 pyrimidinyl] 2 pyridinyl]amino] 1 propanol Smiles: